Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fed’s Rosengren Says Expecting 7% GDP Growth This Year

-Reuters

byMichael Horton

June 25, 2021

1 minute read

-Reuters

News

P3 Health Partners Announces Receipt Of Nasdaq Notice Regarding Late Filing Of Periodic Reports

By Benzinga Newsdesk

Today, 8:03 AM

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that on May 18, 2022, it received a notice

PIII

News

‘Maryland Gov. Hogan institutes 30-day state of emergency amid COVID surge, grants more powers to health care’ -Baltimore Sun Report

By Benzinga Newsdesk

Today, 8:03 AM

https://www.baltimoresun.com/coronavirus/bs-md-hogan-state-of-emergency-30-days-20220104-q7aqvfhbrzaivhcks3gpgdnopy-story.html

AHPI

Stifel Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $33

By Benzinga Newsdesk

Today, 8:03 AM

Stifel analyst Jonathan Block initiates coverage on Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $33.

SKIN

SVB Leerink Maintains Market Perform on Myriad Genetics, Lowers Price Target to $25

By Benzinga Newsdesk

Today, 8:03 AM

SVB Leerink analyst Puneet Souda maintains Myriad Genetics (NASDAQ:MYGN) with a Market Perform and lowers the price target from $27 to $25.

MYGN

Fed’s Rosengren Says Expecting 7% GDP Growth This Year

Related Posts

P3 Health Partners Announces Receipt Of Nasdaq Notice Regarding Late Filing Of Periodic Reports

‘Maryland Gov. Hogan institutes 30-day state of emergency amid COVID surge, grants more powers to health care’ -Baltimore Sun Report

Stifel Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $33

SVB Leerink Maintains Market Perform on Myriad Genetics, Lowers Price Target to $25